Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-20 Sale | 2024-02-22 8:17 pm | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew Chief Legal Officer | 7,606 | $0.68 | $5,172 | 236,674 (Direct) | View |
| 2023-11-17 Sale | 2023-11-20 9:00 pm | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew Chief Legal Officer | 7,179 | $0.49 | $3,518 | 243,780 (Direct) | View |
| 2023-08-16 Sale | 2023-08-17 8:07 pm | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew Chief Legal Officer | 7,221 | $0.78 | $5,632 | 250,959 (Direct) | View |
| 2023-05-16 Sale | 2023-05-17 8:28 pm | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew Chief Legal Officer | 7,543 | $0.72 | $5,431 | 257,680 (Direct) | View |
| 2023-02-16 Sale | 2023-02-17 8:59 pm | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew Chief Legal Officer | 8,275 | $3 | $24,825 | 265,223 (Direct) | View |
| 2022-11-16 Sale | 2022-11-18 6:04 pm | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew Chief Legal Officer | 8,690 | $3.57 | $31,023 | 272,498 (Direct) | View |
| 2022-08-16 Sale | 2022-08-17 7:40 pm | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel | 3,189 | $4.76 | $15,180 | 613,063 (Direct) | View |
| 2022-05-16 Sale | 2022-05-17 9:38 pm | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel | 3,136 | $3.95 | $12,387 | 117,939 (Direct) | View |
| 2022-02-16 Sale | 2022-02-18 6:18 pm | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel | 3,661 | $10.95 | $40,088 | 121,075 (Direct) | View |
| 2021-11-16 Sale | 2021-11-17 6:09 pm | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel | 6,564 | $13.16 | $86,382 | 86,436 (Direct) | View |
| 2021-08-16 Sale | 2021-08-18 7:02 pm | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel | 1,910 | $13.83 | $26,415 | 72,900 (Direct) | View |
| 2021-05-17 Sale | 2021-05-19 7:07 pm | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel | 1,917 | $18.3 | $35,081 | 74,810 (Direct) | View |
| 2021-02-16 Sale | 2021-02-18 7:06 pm | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel | 2,173 | $22.37 | $48,610 | 76,727 (Direct) | View |
| 2021-02-03 Sale | 2021-02-04 8:44 pm | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel | 5,344 | $19.45 | $103,941 | 78,900 (Direct) | View |
| 2020-11-16 Sale | 2020-11-18 7:07 pm | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel | 1,539 | $16.93 | $26,055 | 49,850 (Direct) | View |
| 2020-08-17 Sale | 2020-08-19 6:40 pm | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel | 1,529 | $19.67 | $30,075 | 51,389 (Direct) | View |
| 2020-05-18 Sale | 2020-05-20 6:32 pm | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel | 1,529 | $22.51 | $34,418 | 52,418 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-12-13 Option Award | 2023-12-15 6:05 pm | N/A 2031-12-12 | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew Chief Legal Officer | 325,000 | $0 | 325,000 (Direct) | View |
| 2022-08-15 Option Award | 2022-08-17 7:40 pm | N/A 2030-08-14 | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel | 497,813 | $0 | 613,063 (Direct) | View |
| 2021-12-16 Option Award | 2021-12-20 8:27 pm | N/A 2029-12-15 | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel | 104,950 | $0 | 191,886 (Direct) | View |
| 2021-11-15 Option Award | 2021-11-17 6:09 pm | N/A N/A | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel | 20,100 | $0 | 86,436 (Direct) | View |
| 2021-10-12 Option Award | 2021-10-14 9:09 pm | N/A 2027-12-11 | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel | 35,800 | $0 | 35,800 (Direct) | View |
| 2021-02-03 Exercise | 2021-02-04 8:44 pm | 2017-02-06 2021-02-05 | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel | 5,344 | $0 | 78,900 (Direct) | View |
| 2021-02-03 Exercise | 2021-02-04 8:44 pm | N/A N/A | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel | 5,344 | $8.8 | 78,900 (Direct) | View |
| 2020-12-18 Option Award | 2020-12-22 6:52 pm | N/A 2028-12-17 | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel | 79,550 | $0 | 129,900 (Direct) | View |
Ownership | 2020-04-08 7:53 pm | N/A N/A | NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel | 0 | $0 | 351,416 (Direct) | View |